Previous Close | 4.7000 |
Open | 4.7000 |
Bid | 3.6000 |
Ask | 4.2000 |
Strike | 10.00 |
Expire Date | 2024-10-18 |
Day's Range | 4.7000 - 4.7000 |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
Merck (MRK) exercises the option that will convert the collaboration deal with partner Orion for prostate cancer candidate opevesostat into a license agreement.
Here, we discuss some reasons why buying Bioventus (BVS) stock now may turn out to be a prudent move.
J&J (JNJ) seeks expanded use of its HIV-1 therapy, Prezcobix, for younger kids in the United States and Europe.